Sugi Predict

Sugi Predict / Compounds / SCHEMBL478342

SCHEMBL478342

SCHEMBL478342

Cc1ccc(S(=O)(=O)OCCOCCOCCOCCOCCOS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.53
▸ CA1 P00915 3/20 0.49
▸ CA9 Q16790 3/20 0.49
▸ CA12 O43570 2/20 0.49
▸ GAA P10253 2/20 0.46
▸ STAT3 P40763 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ CA2 P00918 2/20 0.43
▸ CA3 P07451 1/20 0.43
▸ CA6 P23280 1/20 0.43
▸ CA5A P35218 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA5B Q9Y2D0 1/20 0.43
▸ VDR P11473 1/20 0.42
▸ TLR9 Q9NR96 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ CYP2D6 P10635 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18644929 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL18613994 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL12865316 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL4379133 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL1145153 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL881292 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL922407 1.00 ALDH1A1 (0.53) ALDH1A1CA1CA9CA12GAA
SCHEMBL241884 0.94 CA1 (0.52) ALDH1A1CA1CA9CA12GAA
SCHEMBL25398474 0.93 ALDH1A1 (0.47) ALDH1A1CA1CA9CA12GAA
SCHEMBL1218220 0.93 ALDH1A1 (0.47) ALDH1A1CA1CA9CA12GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120136898-A Molecular trefoil compound and synthesis method thereof 华东师范大学 2025-06-13 — — CN claimed
CN-119285682-A X-ray luminescent material and synthesis method and application thereof 中国科学院福建物质结构研究所 2025-01-10 — — CN claimed
CN-118290412-A Glutamate dehydrogenase degradation agent and preparation method and application thereof 杭州汉菁生物科技有限公司 2024-07-05 — — CN claimed
CN-116730973-B 4-tert-butyl benzyloxy substituted calixarene crown ether compound as well as preparation method and application thereof 兰州大学 2023-10-20 — — CN claimed
CN-116730973-A 4-tert-butyl benzyloxy substituted calixarene crown ether compound as well as preparation method and application thereof 兰州大学 2023-09-12 — — CN claimed
CN-111589420-A Millimeter-grade macroporous-mesoporous carbon sphere/cup [4] -double crown-6 interpenetrating composite material and preparation method and application thereof 东华理工大学 2020-08-28 — — CN claimed
EP-3886904-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2026-04-22 — — EP disclosed
US-20250325673-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-10-23 — — US disclosed
EP-4613773-A2 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
EP-3731869-B1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS INC (US) 2025-07-23 — — EP disclosed
US-20250163042-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-05-22 — — US disclosed
US-12258341-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2025-03-25 — — US disclosed
WO-2025040451-A1 HYDROLYSIS RESISTANCE OF POLYURETHANE FOAMS EVONIK OPERATIONS GMBH (DE) 2025-02-27 — — WO disclosed
EP-0670840-B1 BIS-CROWN CALIX[4]ARENES, METHOD FOR PREPARING SAME AND USE THEREOF FOR SELECTIVELY RECOVERING CESIUM AND ACTINIDES COMMISSARIAT ENERGIE ATOMIQUE (FR) 1997-01-22 — — EP disclosed
US-5439511-A Composition containing polymer obtained by polymerizing unsaturated acid anhydride and another unsaturated compound, specified additive HITACHI CHEMICAL COMPANY, LTD. (JP) 1995-08-08 — — US disclosed
EP-0608132-A1 Coating varnish composition and antifouling coating composition HITACHI CHEMICAL CO., LTD. (JP) 1994-07-27 — — EP disclosed
EP-0341409-B1 Platinum (II) complexes, their preparation and use as antitumour agents BOEHRINGER MANNHEIM ITALIA (IT) 1993-12-29 — — EP disclosed
EP-0415939-A1 PLATINUM(II) COMPLEXES, THEIR PREPARATION AND USE AS ANTI-TUMOUR AGENTS BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1991-03-13 — — EP disclosed
EP-0341409-A1 Platinum (II) complexes, their preparation and use as antitumour agents BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) 1989-11-15 — — EP disclosed
WO-1989009218-A1 PLATINUM(II) COMPLEXES, THEIR PREPARATION AND USE AS ANTI-TUMOUR AGENTS BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) 1989-10-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325673-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 ALDH1A1 2776/4885CA1 4622/4885CA9 3970/4885
US-12258341-B2 IRAK degraders and uses thereof IRAK2, IRAK3, IRAK1 ALDH1A1 2776/4885CA1 4622/4885CA9 3970/4885
US-20250163042-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 ALDH1A1 2776/4885CA1 4622/4885CA9 3970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.